<table-wrap id="pone-0018424-t001" position="float"> 
 <object-id pub-id-type="doi">
  10.1371/journal.pone.0018424.t001
 </object-id> 
 <label>Table 1</label>  
 <title>Targeted Morphoproteomic Profiling of Ewing Sarcoma Patients Treated with Insulin-like Growth Factor-1 Receptor (IGF-1R) Inhibitor: Pretreatment Specimens.</title>  
 <alternatives> 
  <graphic id="pone-0018424-t001-1" xlink:href="pone.0018424.t001"></graphic> 
  <table frame="hsides" rules="groups"> 
   <colgroup span="1"> 
    <col align="left" span="1" /> 
    <col align="center" span="1" /> 
    <col align="center" span="1" /> 
    <col align="center" span="1" /> 
    <col align="center" span="1" /> 
    <col align="center" span="1" /> 
    <col align="center" span="1" /> 
   </colgroup> 
   <thead> 
    <tr> 
     <td align="left" colspan="1" rowspan="1"></td>
     <td align="left" colspan="2" rowspan="1">Ras/Raf kinase/Extracellular Signal-Regulated Kinase (ERK) Pathway
      <xref ref-type="table-fn" rid="nt101">
       *
      </xref> </td>
     <td align="left" colspan="2" rowspan="1">mTORC2 Pathway
      <xref ref-type="table-fn" rid="nt101">
       *
      </xref> </td>
     <td align="left" colspan="1" rowspan="1">STAT3 Pathway</td>
     <td align="left" colspan="1" rowspan="1">Nestin</td> 
    </tr> 
   </thead> 
   <tbody> 
    <tr> 
     <td align="left" colspan="1" rowspan="1">Patient No</td>
     <td align="left" colspan="1" rowspan="1">CD99 (Plasmalemmal)</td>
     <td align="left" colspan="1" rowspan="1">p-ERK &frac12; Thr 202/Tyr 204 [Nuclear]</td>
     <td align="left" colspan="1" rowspan="1">p-Akt Ser 473 [Nuclear]</td>
     <td align="left" colspan="1" rowspan="1">p-mTOR Ser2448[Nuclear];</td>
     <td align="left" colspan="1" rowspan="1">p-STAT3
      <xref ref-type="table-fn" rid="nt102">
       **
      </xref> Tyr 705 [Nuclear]</td>
     <td align="left" colspan="1" rowspan="1">(Cytoplasmic)</td> 
    </tr> 
    <tr> 
     <td align="left" colspan="1" rowspan="1">1</td>
     <td align="left" colspan="1" rowspan="1">Present (1+)</td>
     <td align="left" colspan="1" rowspan="1">Present (1–3+)</td>
     <td align="left" colspan="1" rowspan="1">+/−</td>
     <td align="left" colspan="1" rowspan="1">1+</td>
     <td align="left" colspan="1" rowspan="1">&lt;10%</td>
     <td align="left" colspan="1" rowspan="1">0</td> 
    </tr> 
    <tr> 
     <td align="left" colspan="1" rowspan="1">2</td>
     <td align="left" colspan="1" rowspan="1">Present (2+)</td>
     <td align="left" colspan="1" rowspan="1">Present (0–3+)</td>
     <td align="left" colspan="1" rowspan="1">2+</td>
     <td align="left" colspan="1" rowspan="1">2+</td>
     <td align="left" colspan="1" rowspan="1">&gt;50%</td>
     <td align="left" colspan="1" rowspan="1">1</td> 
    </tr> 
   </tbody> 
  </table> 
 </alternatives> 
 <table-wrap-foot> 
  <fn id="nt101"> 
   <label></label> 
   <p>*Maximum scoring intensity graded on a scale of 0 (no signal) to 3+ (high intensity).</p> 
  </fn> 
  <fn id="nt102"> 
   <label></label> 
   <p>**Percentage of positive tumoral nuclei.</p> 
  </fn> 
 </table-wrap-foot> 
</table-wrap>